Buradasınız

Anasayfa » Content

TEKRARLAYAN DOZLARDA AKTİF KÖMÜR TEDAVİSİ SIRASINDA GELİŞEN GASTRİK OBSTRÜKSİYON

A GASTRIC OBSTRUCTION DURING THE MULTI-DOSE ACTIVATED CHARCOAL TREATMENT

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
In this study, it was aimed to rise a notice of gastric obstruction, a rare complication of multidose activated charcoal treatment of organophosphate poisoning, because of a case. Clinical signs that thought to be an intestinal obstruction was recognized in a 65 aged male patient who was treated with multi-dose activated charcoal because of organophosphate poisoning. Some solid images could be related to activated charcoal determined by the computerized tomography. These congromelates were emptied by endoscopy since the gastric lavage was insufficient. A gastrointestinal obstruction may develope during the multi-dose activated charcoal treatment. In this case it is important to being aware of this complication and managing it in the appropirate time.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada, organofosfat zehirlenmesi olgusu nedeni ile tekrarlayan dozlarda aktif kömür uygulanmasının nadir bir komplikasyonu olan gastrik obstrüksiyona dikkat çekilmesi amaçlandı. 65 yaşında organofosfat zehirlenmesi nedeni ile tekrarlayan aktif kömür tedavisi uygulanan erkek hastada, tedavinin ikinci günü intestinal obstrüksiyon düşündüren klinik bulgular gözlendi. Bilgisayarlı tomografi ile değerlendirilen hastanın midesinde solid oluşumlar tespit edildi. Bunların aktif kömüre ait olabileceği düşünüldü. Gastrik lavaj ile aktif kömür birikintisi boşaltılamayınca endoskopik girişim ile bu oluşumlar temizlendi. tekrarlayan dozlarda aktif kömür tedavisi sırasında gastrointestinal obstruksiyon gelişebilir. Bu durumda dikkatli olmak ve zamanında müdahale etmek önemlidir.
FULL TEXT (PDF): 
PDF icon arastirmax-tekrarlayan-dozlarda-aktif-komur-tedavisi-sirasinda-gelisen-gastrik-obstruksiyon.pdf
  • 4
219-222
  • Turkish

REFERENCES

References: 

1. WHO in collaboration with UNEP. Public
health impact of pesticides used in
agriculture. Geneva: World Health
Organization, 1990
2. Robey WC, Meggs WJ. Insecticides,
Herbicides and Rodenticides. In: Tintinalli
JE, Kelen GD, Stapczynski JS, eds.
Emergency Medicine: a Comprehensive
Study Guide. 6th Edn. McGraw-Hill Co,
New York, 2004; pp. 1134-43. .
3. Maura LS, Nawarskas JJ, Mauro VF.
Misadventures with activated charcoal
and recommendations for safe use. Ann
Pharmacother 1994 ; 28: 915-24
4 Sarıtaş A, Çakır Z, Aslan Ş. Organofosfat
ve Karbamat Zehirlenmeleri. The
Euroasian j Med 2007; 39: 55-9
5. Bond GR. The role of activated charcoal
and gastric emptying in gastrointestinal
decontamination: a state-of-the-art
review. Ann Emerg Med 2002; 39: 273-86
6. Watson WA. Factors influencing the clinical
efficacy of activated charcoal. Drug Intel
Clin Pharm 1987;21: 160- 6.
7. Dorrington CL, Johnson DW, Brant R. The
frequency of complications associated
with the use of multiple-dose activated
charcoal. Ann Emerg Med 2003;41: 370- 7
8. Moll J, Kerns W, Tomaszewski C, Rose
R. Incidence of aspiration pneumonia in
intubated patients receiving activated
charcoal. J Emerg Med 1999;17: 279- 83.
9. Watson WA, Cremer KF, Chapman JA.
Gastrointestinal obstruction associated
with multiple-dose activated charcoal. J
Emerg Med 1986;4:401-7
10. Chan JC, Saranasuriya C, Waxman BP.
Bezoar causing small bowel obstruction
after repeated activated charcoal
administration. Med J Aust 2005;183:537.
11. Kimura Y, Kamada Y, Kimura S. Efficacy
of abdominal computed tomography
and nasogastric tube in acute poisoning
patients. Am J Emerg Med 2008;26:738.
12. Schwerk C, Schulz M, Schwerk N,
Blüher S, Kiess W, Siekmeyer W.
Etilefrinhydrochloride tablet ingestion:
successful therapy by endoscopic removal
of tablet conglomerate. Klin Padiatr
2009;221:93-6.

Thank you for copying data from http://www.arastirmax.com